# OnCo record intocell (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/intocell/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "intocell" ;
  schema:name "IntoCell"@en ;
  schema:alternateName "IntoCell, Inc"@en, "인투셀"@en ;
  schema:description "IntoCell is a Korean company that develops the chemical linkers and drug payloads used to build antibody-drug conjugates, antibodies that carry a cell-killing drug to cancer cells. Its first own candidate, ITC-6146RO, entered a phase 1 trial in 2026."@en ;
  schema:url <https://onco.cc/companies/intocell/>, <https://www.intocell.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.intocell.com/>, <https://intocell.com/bbs/content.php?co_id=history>, <https://clinicaltrials.gov/study/NCT07423117> ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> .